UQUIFA maintains a team of highly trained regulatory experts in each of its main sites. As such, UQUIFA develops DMF's/CTD’s for advanced intermediates as well as for the final APIs.

Currently there are 40 Type II DMF’s filed with the FDA and more than 150 active DMF’s worldwide.
UQUIFA has many years of successful experience of being audited by the Regulatory authorities from many countries, including the FDA.

• Last FDA inspections
• List of active US DMF's
• List of CoS